(3.235.105.97)
Users online: 2768    [ij] [ij] [ij] 
Email id
 

Asian Journal of Pharmacy and Technology
Year : 2020, Volume : 10, Issue : 3
First page : ( 179) Last page : ( 182)
Print ISSN : 2231-5705. Online ISSN : 2231-5713.
Article DOI : 10.5958/2231-5713.2020.00030.6

Bimatoprost, also known as Latisse or Lumigan, belongs to a group of drugs called prostamides: A Review

Jain Mayur S.*, Barhate Shashikant D.

Shree Sureshadada Jain Institutes of Pharmaceutical Education and Research, Jammer, Maharashtra, (India)

*Corresponding Author E-mail: mayurjain176@gmail.com

Online published on 16 September, 2020.

Abstract

Bimatoprost, also well-known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug. [1,2]

Top

Keywords

Bimatoprost, Latisse, Lumigan.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
447,110,715 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.